Abstract
Purpose: To investigate the long-term effect of phacoemulsification on intraocular pressure (IOP) in patients with ocular hypertension and open-angle glaucoma. Setting: Three multispecialty ophthalmology practices and one glaucoma specialty group. Design: Retrospective comparative case series. Methods: Review of medical records of patients with open-angle glaucoma or ocular hypertension who had had unilateral phacoemulsification (without other prior or concurrent ophthalmic procedure) with the fellow eye remaining phakic at least 3 years postoperatively. Results: Preoperatively, the IOP in the surgical and fellow eyes in the 29 patients was 15.66 mm Hg ± 3.33 (SD) and 15.64 ± 4.23 mm Hg (P=.98), respectively. Postoperatively, it was 13.56 ± 2.04 mm Hg and 14.92 ± 2.85 mm Hg, respectively, at 4.5 months (P=.06); 14.88 ± 3.20 mm Hg and 15.27 ± 3.19 mm Hg, respectively, at 1 year (P=.67); 14.16 ± 2.61 mm Hg and 14.95 ± 2.79 mm Hg, respectively, at 2 years (P=.37); and 14.68 ± 3.44 mm Hg and 14.68 ± 2.68 mm Hg at 3 years (P=1.00), respectively. There was no significant difference in the mean number of IOP-lowering medications used in the surgical eyes (1.96 ± 1.40) and fellow eyes (2.08 ± 1.44) postoperatively (P=.77). Conclusions: In a cohort of ocular hypertensive and glaucoma patients, uncomplicated phacoemulsification had no significant IOP-lowering effect compared with the phakic fellow eye for up to 3 years postoperatively. There was also no difference between the mean number of postoperative IOP-lowering medications used in the surgical and fellow eyes. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.
| Original language | English |
|---|---|
| Pages (from-to) | 866-870 |
| Number of pages | 5 |
| Journal | Journal of Cataract and Refractive Surgery |
| Volume | 38 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2012 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Ophthalmology
- Sensory Systems
- Surgery
Cite this
Long-term effect of phacoemulsification on intraocular pressure using phakic fellow eye as control. / Chang, Ta; Budenz, Donald L.; Liu, Anthony; Kim, Won I.; Dang, Tam; Li, Chan; Iwach, Andrew G.; Radhakrishnan, Sunita; Singh, Kuldev.
In: Journal of Cataract and Refractive Surgery, Vol. 38, No. 5, 01.05.2012, p. 866-870.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Long-term effect of phacoemulsification on intraocular pressure using phakic fellow eye as control
AU - Chang, Ta
AU - Budenz, Donald L.
AU - Liu, Anthony
AU - Kim, Won I.
AU - Dang, Tam
AU - Li, Chan
AU - Iwach, Andrew G.
AU - Radhakrishnan, Sunita
AU - Singh, Kuldev
PY - 2012/5/1
Y1 - 2012/5/1
N2 - Purpose: To investigate the long-term effect of phacoemulsification on intraocular pressure (IOP) in patients with ocular hypertension and open-angle glaucoma. Setting: Three multispecialty ophthalmology practices and one glaucoma specialty group. Design: Retrospective comparative case series. Methods: Review of medical records of patients with open-angle glaucoma or ocular hypertension who had had unilateral phacoemulsification (without other prior or concurrent ophthalmic procedure) with the fellow eye remaining phakic at least 3 years postoperatively. Results: Preoperatively, the IOP in the surgical and fellow eyes in the 29 patients was 15.66 mm Hg ± 3.33 (SD) and 15.64 ± 4.23 mm Hg (P=.98), respectively. Postoperatively, it was 13.56 ± 2.04 mm Hg and 14.92 ± 2.85 mm Hg, respectively, at 4.5 months (P=.06); 14.88 ± 3.20 mm Hg and 15.27 ± 3.19 mm Hg, respectively, at 1 year (P=.67); 14.16 ± 2.61 mm Hg and 14.95 ± 2.79 mm Hg, respectively, at 2 years (P=.37); and 14.68 ± 3.44 mm Hg and 14.68 ± 2.68 mm Hg at 3 years (P=1.00), respectively. There was no significant difference in the mean number of IOP-lowering medications used in the surgical eyes (1.96 ± 1.40) and fellow eyes (2.08 ± 1.44) postoperatively (P=.77). Conclusions: In a cohort of ocular hypertensive and glaucoma patients, uncomplicated phacoemulsification had no significant IOP-lowering effect compared with the phakic fellow eye for up to 3 years postoperatively. There was also no difference between the mean number of postoperative IOP-lowering medications used in the surgical and fellow eyes. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.
AB - Purpose: To investigate the long-term effect of phacoemulsification on intraocular pressure (IOP) in patients with ocular hypertension and open-angle glaucoma. Setting: Three multispecialty ophthalmology practices and one glaucoma specialty group. Design: Retrospective comparative case series. Methods: Review of medical records of patients with open-angle glaucoma or ocular hypertension who had had unilateral phacoemulsification (without other prior or concurrent ophthalmic procedure) with the fellow eye remaining phakic at least 3 years postoperatively. Results: Preoperatively, the IOP in the surgical and fellow eyes in the 29 patients was 15.66 mm Hg ± 3.33 (SD) and 15.64 ± 4.23 mm Hg (P=.98), respectively. Postoperatively, it was 13.56 ± 2.04 mm Hg and 14.92 ± 2.85 mm Hg, respectively, at 4.5 months (P=.06); 14.88 ± 3.20 mm Hg and 15.27 ± 3.19 mm Hg, respectively, at 1 year (P=.67); 14.16 ± 2.61 mm Hg and 14.95 ± 2.79 mm Hg, respectively, at 2 years (P=.37); and 14.68 ± 3.44 mm Hg and 14.68 ± 2.68 mm Hg at 3 years (P=1.00), respectively. There was no significant difference in the mean number of IOP-lowering medications used in the surgical eyes (1.96 ± 1.40) and fellow eyes (2.08 ± 1.44) postoperatively (P=.77). Conclusions: In a cohort of ocular hypertensive and glaucoma patients, uncomplicated phacoemulsification had no significant IOP-lowering effect compared with the phakic fellow eye for up to 3 years postoperatively. There was also no difference between the mean number of postoperative IOP-lowering medications used in the surgical and fellow eyes. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.
UR - http://www.scopus.com/inward/record.url?scp=84859884215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859884215&partnerID=8YFLogxK
U2 - 10.1016/j.jcrs.2012.01.016
DO - 10.1016/j.jcrs.2012.01.016
M3 - Article
C2 - 22370470
AN - SCOPUS:84859884215
VL - 38
SP - 866
EP - 870
JO - Journal of Cataract and Refractive Surgery
JF - Journal of Cataract and Refractive Surgery
SN - 0886-3350
IS - 5
ER -